CSL (CSLLY) News Today $88.73 +0.51 (+0.58%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period CSL CEO Adjusts Holdings in Company SecuritiesNovember 5, 2024 | markets.businessinsider.comCSL Limited Issues New Employee Incentive SecuritiesNovember 5, 2024 | markets.businessinsider.comCSL shares are in the red for 2024. Are they a buy?November 4, 2024 | msn.comShould Weakness in CSL Limited's (ASX:CSL) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?November 4, 2024 | finance.yahoo.comCSL Limited Resolutions Passed Amid Shareholder DissentOctober 30, 2024 | markets.businessinsider.comShort Interest in CSL Limited (OTCMKTS:CSLLY) Expands By 25.0%CSL Limited (OTCMKTS:CSLLY - Get Free Report) was the target of a significant growth in short interest in the month of October. As of October 15th, there was short interest totalling 500 shares, a growth of 25.0% from the September 30th total of 400 shares. Based on an average daily volume of 38,300 shares, the short-interest ratio is currently 0.0 days.October 29, 2024 | marketbeat.comCSL (CMXHF) Gets a Buy from JardenOctober 26, 2024 | markets.businessinsider.comCiti Reaffirms Their Buy Rating on CSL (CMXHF)October 23, 2024 | markets.businessinsider.comCSL Limited Hosts 2024 R&D Investor BriefingOctober 22, 2024 | markets.businessinsider.comCSL pulls studies, trials on three therapies in late-stage setbackOctober 22, 2024 | afr.comWhy the CSL share price 'looks undervalued'October 20, 2024 | msn.comNew Data Presented at IDWeek 2024 Show Adjuvanted and High-Dose Influenza Vaccines are Comparable in Protecting Adults 65 Years of Age and Older Against Seasonal InfluenzaOctober 18, 2024 | prnewswire.comCSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the treatment of IgA NephropathyOctober 17, 2024 | prnewswire.comCSL Seqirus Presents Data at IDWeek 2024 Highlighting the Urgent Need to Increase Influenza Vaccination Rates and the Benefits of Cell-Based Influenza VaccinesOctober 16, 2024 | prnewswire.comCSL Limited (OTCMKTS:CSLLY) Short Interest UpdateCSL Limited (OTCMKTS:CSLLY - Get Free Report) saw a significant drop in short interest during the month of September. As of September 30th, there was short interest totalling 400 shares, a drop of 90.5% from the September 15th total of 4,200 shares. Based on an average daily trading volume, of 28,400 shares, the short-interest ratio is presently 0.0 days.October 10, 2024 | marketbeat.comCSL Seqirus, a Global Leader in Pandemic Preparedness, Announces Sixth BARDA Award in Response to Avian InfluenzaOctober 4, 2024 | prnewswire.comCSL Seqirus Presents Real-World Evidence at OPTIONS XII Conference Highlighting Effectiveness of Influenza VaccinationsOctober 1, 2024 | prnewswire.comGlenn Fishwick Joins CSL Group as Chief Technology Officer to Lead Innovation in Secure Connectivity SolutionsOctober 1, 2024 | tmcnet.comCSL, Arcturus's Sa-mRNA COVID-19 Vaccine Shows Positive Immune Response; Stock UpSeptember 30, 2024 | markets.businessinsider.comArcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's Comirnaty Shot, Even At Lower DosesSeptember 30, 2024 | finance.yahoo.comSelf-Amplifying mRNA COVID-19 Vaccine Demonstrates Superior Immune Response Compared with mRNA Vaccine at 12 Months Post-VaccinationSeptember 30, 2024 | prnewswire.comCSL gets $121 mln contract to increase US stockpile for bird flu vaccines to 40 mln dosesSeptember 26, 2024 | reuters.comCSL Seqirus, a Global Leader in Pandemic Preparedness, Announces Fifth BARDA Award in Response to Avian Influenza OutbreakSeptember 25, 2024 | prnewswire.comVeltassa® (patiromer) approved in Japan for the treatment of adults with hyperkalemiaSeptember 24, 2024 | prnewswire.comDown 6% in a month: Is it time to buy CSL shares?September 24, 2024 | msn.comJapan Approves CSL and Arcturus Therapeutics’ Novel COVID-19 Vaccine KOSTAIVESeptember 18, 2024 | msn.comMark Cuban Foundation and CSL Bring Free AI Bootcamp to Philadelphia TeensSeptember 17, 2024 | globenewswire.comCSL Joins Accumulus Synergy to Drive Industry ChangeSeptember 17, 2024 | globenewswire.comCSL Limited (OTCMKTS:CSLLY) Short Interest Down 33.3% in AugustCSL Limited (OTCMKTS:CSLLY - Get Free Report) was the target of a significant decline in short interest in August. As of August 31st, there was short interest totalling 1,800 shares, a decline of 33.3% from the August 15th total of 2,700 shares. Based on an average trading volume of 35,700 shares, the days-to-cover ratio is presently 0.1 days.September 15, 2024 | marketbeat.comJapan's Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics' Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika PharmaSeptember 13, 2024 | prnewswire.comCSL Limited (OTCMKTS:CSLLY) Sees Large Decrease in Short InterestCSL Limited (OTCMKTS:CSLLY - Get Free Report) was the target of a large decrease in short interest during the month of August. As of August 15th, there was short interest totalling 2,700 shares, a decrease of 27.0% from the July 31st total of 3,700 shares. Based on an average daily volume of 42,600 shares, the short-interest ratio is currently 0.1 days.August 30, 2024 | marketbeat.comCSL Limited: Good Results Overshadowed By Below-Expectations GuidanceAugust 19, 2024 | seekingalpha.comAnalysts Conflicted on These Healthcare Names: CSL (OtherCMXHF), Pro Medicus Limited (OtherPMCUF) and Takeda Pharmaceutical Co (OtherTKPHF)August 18, 2024 | markets.businessinsider.comCSL Full Year 2024 Earnings: EPS Misses ExpectationsAugust 15, 2024 | finance.yahoo.comMorgans Sticks to Their Buy Rating for CSL (CMXHF)August 15, 2024 | markets.businessinsider.comCSL results: ASX 200 giant announces solid earnings but shares fallAugust 15, 2024 | morningstar.com.auCSL (CMXHF) Receives a Buy from UBSAugust 15, 2024 | markets.businessinsider.comCSL shares on watch amid US$3b FY 2024 profitAugust 14, 2024 | msn.comCSL Limited (CSLLY) Q4 2024 Earnings Call TranscriptAugust 14, 2024 | seekingalpha.com‘I want to win every time’: The Olympic-style goal driving CSL’s bossAugust 13, 2024 | afr.comRobust demand for blood products drives CSL's growthAugust 12, 2024 | msn.comCSL Annual Profit Rises by 20% on Immunoglobulins Growth -- UpdateAugust 12, 2024 | marketwatch.comCSL share price tumbles after FY25 guidance disappointsAugust 12, 2024 | msn.comCSL Ltd (ASX: CSL) Set to Reveal Earnings and Dividend DetailsAugust 8, 2024 | au.investing.comCSL earnings preview: What to look for in ASX200 heavyweight's resultsAugust 8, 2024 | morningstar.com.auCSL Limited Elliott Wave technical forecast [Video]August 2, 2024 | fxstreet.comTerumo Gaining Share In Growth Markets, But Consistency Still A QuestionJuly 31, 2024 | seekingalpha.comCarlisle (NYSE:CSL) Posts Q2 Sales In Line With EstimatesJuly 25, 2024 | theglobeandmail.comCSL Seqirus Begins Shipping Its Portfolio of Influenza Vaccines for the 2024/25 Flu SeasonJuly 9, 2024 | prnewswire.comCSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in EuropeJuly 4, 2024 | globenewswire.com Get CSL News Delivered to You Automatically Sign up to receive the latest news and ratings for CSLLY and its competitors with MarketBeat's FREE daily newsletter. Email Address JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback. Get your free guide NOW before it's too late. CSLLY Media Mentions By Week CSLLY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CSLLY News Sentiment▼0.000.46▲Average Medical News Sentiment CSLLY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CSLLY Articles This Week▼02▲CSLLY Articles Average Week Get CSL News Delivered to You Automatically Sign up to receive the latest news and ratings for CSLLY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ABBV News Today MRK News Today NVS News Today ABT News Today AZN News Today PFE News Today SNY News Today BMY News Today VRTX News Today REGN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:CSLLY) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CSL Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share CSL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CSLLY Stock Alerts